These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 2308990)
1. The use of immunorosettes for purging of bone marrow in childhood cancer. Slaper-Cortenbach IC; Wijngaarden-du Bois MJ; Admiraal LG; Tetteroo PA; Figdor CG; van Leeuwen EF Prog Clin Biol Res; 1990; 333():337-44. PubMed ID: 2308990 [No Abstract] [Full Text] [Related]
2. [Monoclonal antibody and purging]. Ueda R; Morishima Y Gan No Rinsho; 1989 May; Spec No():294-302. PubMed ID: 2601016 [No Abstract] [Full Text] [Related]
3. Efficacy of bone marrow purging in AML using monoclonal antibodies and complement. Mills LE; Ball ED; Howell AL; Cornwell GG; Thompson L; Spruce W; Miller WE; McMillan R Prog Clin Biol Res; 1990; 333():165-70. PubMed ID: 2308980 [No Abstract] [Full Text] [Related]
4. Autologous bone marrow transplantation for high risk acute lymphoblastic leukemia: clinical relevance of ex vivo bone marrow purging with monoclonal antibodies and complement. Grañena A; Castellsagué X; Badell I; Ferra C; Ortega J; Brunet S; Puntí C; Sureda A; Picón M; Valls A; Rutllant M; García J Bone Marrow Transplant; 1999 Sep; 24(6):621-7. PubMed ID: 10490727 [TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody 55 (CD10) and complement used for purging autologous bone marrow in common acute lymphoblastic leukemia. Bai Y; Piao XH; Luo QL; Mao BZ Chin Med J (Engl); 1990 May; 103(5):385-90. PubMed ID: 2118055 [TBL] [Abstract][Full Text] [Related]
6. Elimination of clonogenic leukemic cells from bone marrow using monoclonal antibodies and magnetic immunobeads. Murakami S; Shimazaki C; Oku N; Itoh K; Takeda N; Fujita N; Ura Y; Nakagawa M Prog Clin Biol Res; 1990; 333():253-61. PubMed ID: 2308985 [No Abstract] [Full Text] [Related]
7. Autologous bone marrow transplantation for acute lymphoblastic leukemia: role of bone marrow purging. Canals C; Picón M; Sanchez T; Torrico C; Amill B; Tugues D; Sierra J; Grañena A; Badell I; Brunet S Prog Clin Biol Res; 1994; 389():125-32. PubMed ID: 7700894 [No Abstract] [Full Text] [Related]
8. Low antigen density leukemia cells: selection and comparative resistance to antibody-mediated marrow purging. Janssen WE; Lee C; Gross S; Gee AP Exp Hematol; 1989 Mar; 17(3):252-7. PubMed ID: 2917623 [TBL] [Abstract][Full Text] [Related]
9. Immunomagnetic microsphere mediated purging of cALLa positive leukemic cells from bone marrow for autologous reinfusion. Janssen WE; Lee C; Johnson KS; Spencer C; Rios AM; Graham-Pole JR; Gross S Prog Clin Biol Res; 1990; 333():285-92. PubMed ID: 2137931 [TBL] [Abstract][Full Text] [Related]
10. Bone marrow purging with immunotoxins for treatment of T cell acute lymphoblastic leukemia (T-ALL). Vallera DA; Uckun FM Prog Clin Biol Res; 1990; 333():191-204; discussion 205. PubMed ID: 2308981 [No Abstract] [Full Text] [Related]
11. In vitro treatment of autologous bone marrow for neuroblastoma patients with anti GD2 monoclonal antibody and human complement: a pilot study. Stein J; Strandjord S; Saarinen U; Warkentin P; Gerson S; Lazarus H; Von Hoff D; Coccia P; Cheung NK Prog Clin Biol Res; 1988; 271():237-48. PubMed ID: 3043451 [No Abstract] [Full Text] [Related]
12. CD9 is an unreliable antibody for bone marrow purging. Fort JA; Rios AM; Gross S; Janssen WE Prog Clin Biol Res; 1990; 333():185-9. PubMed ID: 2408060 [TBL] [Abstract][Full Text] [Related]
13. The effect of DNAse on the detection of residual malignant cells by polymerase chain reaction after immunologic purging of autologous bone marrow grafts. Vervoordeldonk SF; Merle PA; Steenbergen EJ; van Leeuwen EF; von dem Borne AE; Slaper-Cortenbach IC Prog Clin Biol Res; 1994; 389():601-9. PubMed ID: 7700926 [No Abstract] [Full Text] [Related]
14. Anti-neuroblastoma monoclonal antibodies which do not bind to bone marrow cells. Frantz CN; Duerst RE; Ryan DH; Gelsomino NL; Constine LS; Gregory PK Prog Clin Biol Res; 1985; 175():485-99. PubMed ID: 3887430 [TBL] [Abstract][Full Text] [Related]
15. Depletion of T cells from human bone marrow with monoclonal antibody CT-2 and complement. Trigg ME; Billing R; Sondel PM; Dickerman JD; Erickson C; Finlay JL; Bozdech M; Hong R; Padilla-Nash H; Terasaki P J Biol Response Mod; 1984 Aug; 3(4):406-12. PubMed ID: 6384432 [TBL] [Abstract][Full Text] [Related]
16. S-L 11.14: a monoclonal antibody recognizing neuroectodermal tumors with possible value for bone marrow purging before autograft. Combaret V; Kremens B; Favrot MC; Laurent JC; Philip T Bone Marrow Transplant; 1988 May; 3(3):221-7. PubMed ID: 2844344 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of a monoclonal IgM antibody for purging of bone marrow for autologous transplantation. Zola H; Potter A; Neoh SH; Juttner CA; Haylock DN; Rice AM; Favaloro EJ; Kabral A; Bradstock KF Bone Marrow Transplant; 1987 Feb; 1(3):297-301. PubMed ID: 3332140 [TBL] [Abstract][Full Text] [Related]
18. Autologous BMT in high risk patients with CALLA-positive ALL: possible efficacy of ex vivo marrow leukemia cell purging with monoclonal antibodies and complement. Morishima Y; Miyamura K; Kojima S; Ueda R; Morishita Y; Sao H; Tanimoto M; Ohno R; Sobue R; Hirano M Bone Marrow Transplant; 1993 Apr; 11(4):255-9. PubMed ID: 7683550 [TBL] [Abstract][Full Text] [Related]
19. Removal of neuroblastoma cells from bone marrow by a direct monoclonal antibody rosetting technique. Berthold F; Schumacher R; Schneider A; Bosslet K; Reiter C Bone Marrow Transplant; 1989 May; 4(3):273-8. PubMed ID: 2659112 [TBL] [Abstract][Full Text] [Related]
20. Preclinical evaluation of immunoconjugates consisting of doxorubicin linked to complement-fixing monoclonal antibody DLC-48 for bone marrow purging of B-cell lymphomas. Winter JN; Bass B; Bringman T; Nedwin G Prog Clin Biol Res; 1990; 333():171-83. PubMed ID: 2408059 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]